Track Cyteir Therapeutics's other current assets ($1.4M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Cyteir Therapeutics (CYT) currently reports a other current assets of $1.4M as of September 2023. That compares with $3.4M in the prior-year period — down 59.3% year over year. Use the charts on this page to explore Cyteir Therapeutics's other current assets history and peer comparisons.
Cyteir Therapeutics's other current assets decreased from $3.4M to $1.4M — a 59.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cyteir Therapeutics reported $1.4M in other current assets as of September 2023. That compares with $3.4M in the prior-year period — down 59.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current assets of $1.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyteir Therapeutics, and consider following CYT for alerts when major investors trade the stock.
Cyteir Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $1.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYT with unrelated industries.